John M. Kovarik,Robert Schmouder,Marie-Claude Bastien,Olivier David,Goeril Karlsson
申请号：
US15902628
公开号：
US20180177747A1
申请日:
2018.02.22
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to pharmaceutical compositions comprising a 2-amino-2-[2-(4-C2-20- alkyl-phenyl)ethyl]propane-1,3-diol compound or a pharmaceutically acceptable salt thereof, and to the use thereof for treating, preventing or delaying the progression of multiple sclerosis in a paediatric patient or a patient suffering from a specific condition.
